Föreläsningar och seminarier OnkPat Extra Seminar: Julian Lum

2021-09-09 16:00 Add to iCal
Zoom

Autophagy in Cancer Immunity

Join Zoom Meeting

https://ki-se.zoom.us/j/63343530214?pwd=TzQyaTNTYU1pUzA0YzJVZnltMjRHdz09

 

Title:
“Autophagy in Cancer Immunity”

Julian Lum, PhD
Deeley Research Centre, BC Cancer, Victoria, BC, Canada

www.lumlab.ca @lum_lab

Host: Katja Pokrovskaja Tamm

One of the goals in Julian’s research is to develop new strategies to genetically enhance T cell metabolism as a means to overcome the suppressive metabolic environment in tumors. Julian’s team aims to understand how the metabolic ecosystem in tumors impact host antitumor immunity, and, specifically, autophagy-mediated control of immune responses in ovarian cancer. Dr. Lum’s laboratory is using unique human tissue resources at BC Cancer to interrogate and uncover the metabolomics features of tumor-infiltrating lymphocytes to identify pathways that could be genetically or pharmacologically modified to enhance T cell responses.

The second area is to understand how radiation therapy alters immune responses to cancer. Currently Dr. Lum is investigating new immunotherapy combinations with radiation (e.g. external bead, brachytherapy, radio-targeting ligands) including a Phase 1 trial of focal radiation and checkpoint blockade for ovarian cancer.

Some reading:

Kilgour MK, … Lum JJ. 1-Methylnicotinamide is an immune regulatory metabolite in human ovarian cancer. Sci Adv. 2021 Jan 20;7(4):eabe1174. PMID: 33523930 1-Methylnicotinamide is an immune regulatory metabolite in human ovarian cancer (nih.gov)

Carleton G, Lum JJ. Autophagy metabolically suppresses CD8+ T cell antitumor immunity. Autophagy. 2019 Jun 14:1-2. PubMed PMID: 31170865.  https://doi.org/10.1080/15548627.2019.1628545 

MacPherson S, Kilgour M, Lum JJ. DeVorkin L, … , Lum JJ. Autophagy Regulation of Metabolism Is Required for CD8(+) T Cell Anti-tumor Immunity. Cell Rep. 2019 Apr9;27(2):502-513.e5. PubMed PMID: 30970253.  https://doi.org/10.1016/j.celrep.2019.03.037

Understanding lymphocyte metabolism for use in cancer immunotherapy. FEBS J. 2018 Jul;285(14):2567-2578. Epub 2018 Apr 17. Review. PubMed PMID: 29611301. https://doi.org/10.1111/febs.14454

Welcome!